Invitation to Capital Markets Day on November 21
Vitrolife AB (publ) hereby invites analysts, investors, shareholders and journalists to a Capital Markets Day on November 21.
We will talk about Vitrolife’s business, which assists in making many people’s desire to have children a reality. We will give an update on the market trends and the strategy together with an update on the operative and financial development. Furthermore, we will present the new partnership with Illumina on preimplantation genetic testing. There will be an opportunity to visit one of our production facilities between approx. 15:30-16:30. The presentations will be held in English.
Time
November 21, at 16:30-18:30
Venue
Vitrolife’s headquarters, Gustaf Werners gata 2, 421 32 Västra Frölunda/Gothenburg
Registration
Please inform Anita Ahlqvist that you will attend by email, investor@vitrolife.com, or by telephone on +46 (0)31–721 80 83, no later than November 5. A light meal will be served, so please inform us of any allergies you may have. There is limited seating.
Gothenburg, October 4, 2018
VITROLIFE AB (publ)
For further information, please contact:
Thomas Axelsson, CEO, 46 31 721 80 01
Mikael Engblom, CFO, 46 31 721 80 14
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
_________________________________________________________________________________________________________________
Vitrolife is an international medical device Group. Vitrolife develops, produces and markets medical devices for assisted reproduction.
Vitrolife has approximately 370 employees and the company's products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.
Vitrolife AB (publ), Box 9080, SE-400 92 Göteborg, Sweden. Corporate identity number 556354-3452. Tel: 46 31 721 80 00. Fax: 46 31 721 80 99. E-mail: info@vitrolife.com. Website: www.vitrolife.com/
Tags: